To study the ability of hydrazine sulfate to influence the poor clinical outcome and nutritional status of patients with advanced non-small cell lung cancer and in adenocarcinoma of the colon in a prospective, double-blind, placebo controlled randomized clinical trial. To correlate alterations in glucose metabolism with objective indices of nutritional and clinical outcome in cancer patients with the above two tumor types.
Showing the most recent 10 out of 1232 publications